About this condition
Familial Adenomatous Polyposis
Familial adenomatous polyposis (FAP) is an autosomal dominant hereditary colorectal cancer syndrome caused by pathogenic variants in the APC (adenomatous polyposis coli) tumor suppressor gene on chromosome 5q22.2. Classic FAP is characterized by the development of hundreds to thousands of adenomatous polyps throughout the colorectum, typically appearing in the second decade of life. Without surgical intervention, colorectal cancer is virtually inevitable by the fifth decade — lifetime colorectal cancer risk approaches 100% in untreated classic FAP. FAP accounts for approximately 0.5-1% of all colorectal cancers and is estimated to affect 1 in 5,000 to 1 in 10,000 individuals.
Attenuated FAP (AFAP) is a milder phenotypic variant caused by variants in specific APC regions (the 5' end, exon 9, or the 3' end) and is characterized by fewer polyps (10-100), later onset of polyposis, lower but still substantially elevated colorectal cancer risk, and more variable expression. Genotype-phenotype correlations in FAP are well-established: variants in codons 1250-1464 (particularly codon 1309) are associated with dense polyposis and earlier colorectal cancer; variants at codons 1310-1330 and 1445-1580 are associated with a higher risk of desmoid tumors; and variants at the 5' end are associated with AFAP. Extracolonic manifestations — including duodenal adenomas (100% lifetime risk), thyroid cancer, hepatoblastoma (in children), desmoid tumors, congenital hypertrophy of the retinal pigment epithelium (CHRPE), and osteomas — vary by APC variant location.
Approximately 20-30% of classic FAP arises from de novo APC variants without a family history of polyposis. An additional 7-10% of patients who meet clinical criteria for FAP have no detectable APC variant by standard sequencing — this group may harbor deep intronic splicing variants, large genomic rearrangements (deletions, duplications), or somatic mosaicism that standard gene panel testing cannot detect. MUTYH-associated polyposis (MAP), caused by biallelic MUTYH variants, can produce a phenotype indistinguishable from attenuated FAP and requires concurrent MUTYH genotyping in APC-negative polyposis patients.
Classic FAP, attenuated FAP (AFAP), and MUTYH-associated polyposis (MAP) produce overlapping clinical pictures with distinct genetic causes and surgical implications. APC variant location determines extracolonic manifestation risk.
- Gene locus
- APC (5q22.2)
